The confirmation clears a key regulatory requirement for Check-Cap advances to complete its previously announced, shareholder ...
The merger with MBody AI received approximately 98% shareholder approval in November 2025 and remains on track for closing.
ISFIYA, ISRAEL, Sept. 12, 2025 (GLOBE NEWSWIRE) -- MBody AI (“MBody AI”) and Check-Cap Ltd. (“Check-Cap” or the “Company”) (NASDAQ: CHEK) today announced that they have entered into a definitive ...
Shares of Check-Cap Ltd. (NASDAQ:CHEK) rose sharply in pre-market trading. MBody AI and Check Cap Ltd announced that they have entered into a definitive merger agreement. David Lontini, Chairman of ...
Check-Cap Ltd. is a clinical stage medical diagnostics company, which engages in the development of ingestible imaging capsule systems for colorectal cancer screening. Its patented technology, C-Scan, ...
Merger to Create Combined Company Focused on Embodied AI for the Autonomous Workforce ISFIYA, ISRAEL, Sept. 12, 2025 (GLOBE NEWSWIRE) -- MBody AI (“MBody AI”) and Check-Cap Ltd. (CHEK) today announced ...